ACHILLION PHARMACEUTICALS, INC. 10,275,000 Shares of Common Stock UNDERWRITING AGREEMENT January 22, 2010Underwriting Agreement • January 22nd, 2010 • Achillion Pharmaceuticals Inc • Pharmaceutical preparations • New York
Achillion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Roth Capital Partners, LLC (“Roth”), Noble Financial Capital Markets and National Securities Corporation (each, an “Underwriter” and, collectively, the “Underwriters”) an aggregate of 10,275,000 shares (the “Securities”) of its common stock, par value $0.001 per share (the “Common Stock”).
